Rankings
▼
Calendar
LNSR Q3 2023 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena
LNSR
LENSAR, Inc.
$142M
Q3 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$10M
+26.4% YoY
Gross Profit
$5M
49.8% margin
Operating Income
-$2M
-20.8% margin
Net Income
$3M
26.2% margin
EPS (Diluted)
$0.21
QoQ Revenue Growth
-18.5%
Cash Flow
Operating Cash Flow
-$339,000
Free Cash Flow
-$341,000
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$71M
Total Liabilities
$34M
Stockholders' Equity
$36M
Cash & Equivalents
$25M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$8M
+26.4%
Gross Profit
$5M
$4M
+25.4%
Operating Income
-$2M
-$4M
+50.0%
Net Income
$3M
-$4M
+164.3%
Revenue Segments
Product
$7M
87%
Service
$1M
13%
Geographic Segments
UNITED STATES
$6M
69%
Asia Excluding South Korea
$1M
13%
Europe
$934,000
11%
Other Geographical Region
$481,000
6%
KOREA, REPUBLIC OF
$9,000
0%
← FY 2023
All Quarters
Q4 2023 →